These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32640421)

  • 1. Cancer-associated fibroblasts-derived gamma-glutamyltransferase 5 promotes tumor growth and drug resistance in lung adenocarcinoma.
    Wei JR; Dong J; Li L
    Aging (Albany NY); 2020 Jul; 12(13):13220-13233. PubMed ID: 32640421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells.
    Li Y; Chen Y; Miao L; Wang Y; Yu M; Yan X; Zhao Q; Cai H; Xiao Y; Huang G
    Cancer Lett; 2021 Jan; 497():212-220. PubMed ID: 33132120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
    Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
    BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.
    Negrete-Garcia MC; Ramírez-Rodriguez SL; Rangel-Escareño C; Muñoz-Montero S; Kelly-García J; Vázquez-Manríquez ME; Santillán P; Ramírez MM; Ramírez-Martínez G; Ramírez-Venegas A; Ortiz-Quintero B
    Tohoku J Exp Med; 2018 Oct; 246(2):107-120. PubMed ID: 30369556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
    Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
    J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thy-1
    Schliekelman MJ; Creighton CJ; Baird BN; Chen Y; Banerjee P; Bota-Rabassedas N; Ahn YH; Roybal JD; Chen F; Zhang Y; Mishra DK; Kim MP; Liu X; Mino B; Villalobos P; Rodriguez-Canales J; Behrens C; Wistuba II; Hanash SM; Kurie JM
    Sci Rep; 2017 Jul; 7(1):6478. PubMed ID: 28744021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
    Tan W; Liao Y; Qiu Y; Liu H; Tan D; Wu T; Tang M; Zhang S; Wang H
    Cancer Lett; 2018 Aug; 428():55-68. PubMed ID: 29702190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Rebollido-Rios R; Venton G; Sánchez-Redondo S; Iglesias I Felip C; Fournet G; González E; Romero Fernández W; Borroto Escuela DO; Di Stefano B; Penarroche-Díaz R; Martin G; Ceylan I; Costello R; Perez-Alea M
    Oncogene; 2020 Mar; 39(13):2756-2771. PubMed ID: 32015486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.
    Kunita A; Morita S; Irisa TU; Goto A; Niki T; Takai D; Nakajima J; Fukayama M
    Sci Rep; 2018 Jun; 8(1):8838. PubMed ID: 29892003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
    Zhou Z; Zhou Q; Wu X; Xu S; Hu X; Tao X; Li B; Peng J; Li D; Shen L; Cao Y; Yang L
    Cancer Lett; 2020 Mar; 473():62-73. PubMed ID: 31904479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling.
    Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Alfaro C; Sanchez JC; Franco F; Calvo V; Romero A; Martin-Acosta P; Salas C; Garcia JM; Provencio M
    Free Radic Biol Med; 2019 Jan; 130():163-173. PubMed ID: 30391585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma.
    Wang Y; Liu S; Dong W; Qu X; Huang C; Yan T; Du J
    Biomed Pharmacother; 2019 May; 113():108779. PubMed ID: 30889488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.
    Ishibashi M; Neri S; Hashimoto H; Miyashita T; Yoshida T; Nakamura Y; Udagawa H; Kirita K; Matsumoto S; Umemura S; Yoh K; Niho S; Tsuboi M; Masutomi K; Goto K; Ochiai A; Ishii G
    Sci Rep; 2017 Apr; 7():46662. PubMed ID: 28429795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretome profiling identifies neuron-derived neurotrophic factor as a tumor-suppressive factor in lung cancer.
    Zhang Y; Wu X; Kai Y; Lee CH; Cheng F; Li Y; Zhuang Y; Ghaemmaghami J; Chuang KH; Liu Z; Meng Y; Keswani M; Gough NR; Wu X; Zhu W; Tzatsos A; Peng W; Seto E; Sotomayor EM; Zheng X
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MACC1 overexpression in carcinoma‑associated fibroblasts induces the invasion of lung adenocarcinoma cells via paracrine signaling.
    Li Z; Guo T; Fang L; Li N; Wang X; Wang P; Zhao S; Li F; Cui Y; Shu X; Zhao L; Li J; Gu C
    Int J Oncol; 2019 Apr; 54(4):1367-1375. PubMed ID: 30720137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cancer-associated fibroblasts and their correlation with microvessel and lymphatic vessel density in lung adenocarcinoma.
    Chen L; Qin Y; Zhang T; Ding N; Chen Y; Zhang Z; Guo C
    J Clin Lab Anal; 2019 May; 33(4):e22832. PubMed ID: 30737838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
    Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
    Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.